It is hypothesized that the kidneys receive about 25% of the circulating blood volume per minute, in addition to the release of vascular endothelial growth factor and other angiogenic factors by RCC, resulting in the hypervascularity of these tumors and their association with arteriovenous shunts contributing to the unique hematogenous route of spread. Here, VEGFA is linked to renal cell adenocarcinoma.